1012249

Abbvie Biotechnology Ltd. — FEI 3004620772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 28, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)